Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. Lancet Oncol. 2019 Mar;20(3):319-321. [PubMed: 30795952]
Pimple SA, Mishra GA. Global strategies for cervical cancer prevention and screening. Minerva Ginecol. 2019 Aug;71(4):313-320. [PubMed: 30808155]
Cervical Cancer Screening Every 5 Years OK. Cancer Discov. 2018 Oct;8(10):1204. [PubMed: 30206109]
Farghaly H, Bourgeois D, Houser PM, Padmanabhan V, Lage JM, Hoda RS. Routine vagin*l Pap test is not useful in women status-post hysterectomy for benign disease. Diagn Cytopathol. 2006 Sep;34(9):640-3. [PubMed: 16900480]
Foran C, Brennan A. Prevention and early detection of cervical cancer in the UK. 2015 May 28-Jun 10Br J Nurs. 24(10):S22-4, S26, S28-9. [PubMed: 26018178]
Pierre-Victor D, Stephens DP, Omondi A, Clarke R, Jean-Baptiste N, Madhivanan P. Barriers to HPV Vaccination Among Unvaccinated, Haitian American College Women. Health Equity. 2018;2(1):90-97. [PMC free article: PMC5994833] [PubMed: 29904749]
Manini I, Montomoli E. Epidemiology and prevention of Human Papillomavirus. Ann Ig. 2018 Jul-Aug;30(4 Supple 1):28-32. [PubMed: 30062377]
Ghosh I, Mandal R, Kundu P, Biswas J. Association of Genital Infections Other Than Human Papillomavirus with Pre-Invasive and Invasive Cervical Neoplasia. J Clin Diagn Res. 2016 Feb;10(2):XE01-XE06. [PMC free article: PMC4800637] [PubMed: 27042571]
Habtemariam LW, Zewde ET, Simegn GL. Cervix Type and Cervical Cancer Classification System Using Deep Learning Techniques. Med Devices (Auckl). 2022;15:163-176. [PMC free article: PMC9208738] [PubMed: 35734419]
Kuhn L, Denny L. The time is now to implement HPV testing for primary screening in low resource settings. Prev Med. 2017 May;98:42-44. [PMC free article: PMC5578476] [PubMed: 28279263]
Rauh-Hain JA, Melamed A, Schaps D, Bregar AJ, Spencer R, Schorge JO, Rice LW, Del Carmen MG. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies. Gynecol Oncol. 2018 Apr;149(1):4-11. [PubMed: 29605048]
Wang X, Huang X, Zhang Y. Involvement of Human Papillomaviruses in Cervical Cancer. Front Microbiol. 2018;9:2896. [PMC free article: PMC6279876] [PubMed: 30546351]
Romero-Masters JC, Lambert PF, Munger K. Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease. Viruses. 2022 Sep 28;14(10) [PMC free article: PMC9611894] [PubMed: 36298698]
Choi PW, Liu TL, Wong CW, Liu SK, Lum YL, Ming WK. The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update. Int J Mol Sci. 2022 Jun 27;23(13) [PMC free article: PMC9266862] [PubMed: 35806128]
Nowakowski A, Cybulski M, Buda I, Janosz I, Olszak-Wąsik K, Bodzek P, Śliwczyński A, Teter Z, Olejek A, Baranowski W. Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland. PLoS One. 2016;11(5):e0155849. [PMC free article: PMC4873170] [PubMed: 27196050]
Lax S. Histopathology of cervical precursor lesions and cancer. Acta Dermatovenerol Alp Pannonica Adriat. 2011 Sep;20(3):125-33. [PubMed: 22131112]
Jenkins D. Histopathology and cytopathology of cervical cancer. Dis Markers. 2007;23(4):199-212. [PMC free article: PMC3851118] [PubMed: 17627056]
Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2020 Dec 31;32(6):720-728. [PMC free article: PMC7797226] [PubMed: 33446995]
Hutchcraft ML, Miller RW. Bleeding from Gynecologic Malignancies. Obstet Gynecol Clin North Am. 2022 Sep;49(3):607-622. [PubMed: 36122988]
Zhdan VM, Holovanova IA, Vovk OY, Korosh MV. RELATIONSHIP BETWEEN CERVICAL CANCER AND THE LEVEL OF PREVENTIVE ONCOLOGICAL EXAMINATIONS. Wiad Lek. 2021;74(6):1428-1432. [PubMed: 34159932]
Burness JV, Schroeder JM, Warren JB. Cervical Colposcopy: Indications and Risk Assessment. Am Fam Physician. 2020 Jul 01;102(1):39-48. [PubMed: 32603071]
Mirpour S, Mhlanga JC, Logeswaran P, Russo G, Mercier G, Subramaniam RM. The role of PET/CT in the management of cervical cancer. AJR Am J Roentgenol. 2013 Aug;201(2):W192-205. [PubMed: 23883234]
Senol T, Polat M, Ozkaya E, Karateke A. Comparison of Two Step LEEP and Cold Conisation For Cervical Intraepithelial Lesions to Decrease Positive Surgical Margins. Asian Pac J Cancer Prev. 2016;17(7):3317-20. [PubMed: 27509969]
Shachner TR, Van Meter SE. Metastatic melanoma of the uterine cervix diagnosed on cervical Pap smear: Case report and literature review. Diagn Cytopathol. 2018 Dec;46(12):1045-1049. [PubMed: 30354020]
Larsson G, Gullberg B, Grundsell H. A comparison of complications of laser and cold knife conization. Obstet Gynecol. 1983 Aug;62(2):213-7. [PubMed: 6408545]
Brun JL, Youbi A, Hocké C. [Complications, sequellae and outcome of cervical conizations: evaluation of three surgical technics]. J Gynecol Obstet Biol Reprod (Paris). 2002 Oct;31(6):558-64. [PubMed: 12407327]
Smith ES, Moon AS, O'Hanlon R, Leitao MM, Sonoda Y, Abu-Rustum NR, Mueller JJ. Radical Trachelectomy for the Treatment of Early-Stage Cervical Cancer: A Systematic Review. Obstet Gynecol. 2020 Sep;136(3):533-542. [PMC free article: PMC7528402] [PubMed: 32769648]
Cibula D, Abu-Rustum NR, Benedetti-Panici P, Köhler C, Raspagliesi F, Querleu D, Morrow CP. New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection. Gynecol Oncol. 2011 Aug;122(2):264-8. [PubMed: 21592548]
Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008 Mar;9(3):297-303. [PubMed: 18308255]
Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, Buda A, Yan X, Shuzhong Y, Chetty N, Isla D, Tamura M, Zhu T, Robledo KP, Gebski V, Asher R, Behan V, Nicklin JL, Coleman RL, Obermair A. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med. 2018 Nov 15;379(20):1895-1904. [PubMed: 30380365]
Li RZ, Sun LF, Li R, Wang HJ. Survival after minimally invasive radical hysterectomy without using uterine manipulator for early-stage cervical cancer: A systematic review and meta-analysis. BJOG. 2023 Jan;130(2):176-183. [PubMed: 36331008]
Bogani G, Di Donato V, Scambia G, Raspagliesi F, Chiantera V, Sozzi G, Golia D'Augè T, Muzii L, Benedetti Panici P, D'Oria O, Vizza E, Giannini A, On Behalf Of The Investigators Of The Italian Gynecological Cancer Study Group Radical Hysterectomy for Early Stage Cervical Cancer. Int J Environ Res Public Health. 2022 Sep 15;19(18) [PMC free article: PMC9517651] [PubMed: 36141917]
Touhami O, Plante M. Minimally Invasive Surgery for Cervical Cancer in Light of the LACC Trial: What Have We Learned? Curr Oncol. 2022 Feb 14;29(2):1093-1106. [PMC free article: PMC8871281] [PubMed: 35200592]
Lécuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Daraï E, Marret H, Magaud L, Gillaizeau F, Chatellier G, Dargent D. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011 May 01;29(13):1686-91. [PubMed: 21444878]
Mathevet P, Lécuru F, Uzan C, Boutitie F, Magaud L, Guyon F, Querleu D, Fourchotte V, Baron M, Bats AS., Senticol 2 group. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2). Eur J Cancer. 2021 May;148:307-315. [PubMed: 33773275]
Baboudjian M, Gondran-Tellier B, Michel F, Abdallah R, Rouy M, Gaillet S, Sichez PC, Boissier R, Bladou F, Lechevallier E, Karsenty G. Miami Pouch: A Simple Technique for Efficient Continent Cutaneous Urinary Diversion. Urology. 2021 Jun;152:178-183. [PubMed: 33581233]
von Knobloch R, Seybold M, Fischer HP, Kibele M, Samad WA. Modification of the Indiana Pouch Ileo-Caecal Cutaneous Continent Urinary Diversion: Tubular Ileal Afferent Limb for Ureteral Anastomosis Has Low Stricture Rate and Allows Ileal Ureter Replacement. Urol Int. 2022;106(2):180-185. [PubMed: 34569528]
Matsuzaki S, Klar M, Chang EJ, Matsuzaki S, Maeda M, Zhang RH, Roman LD, Matsuo K. Minimally Invasive Surgery and Surgical Volume-Specific Survival and Perioperative Outcome: Unmet Need for Evidence in Gynecologic Malignancy. J Clin Med. 2021 Oct 19;10(20) [PMC free article: PMC8537091] [PubMed: 34682910]
Bizzarri N, Chiantera V, Ercoli A, fa*gotti A, Tortorella L, Conte C, Cappuccio S, Di Donna MC, Gallotta V, Scambia G, Vizzielli G. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature. J Minim Invasive Gynecol. 2019 Nov-Dec;26(7):1316-1326. [PubMed: 30611973]
Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014 Sep;134(3):546-51. [PMC free article: PMC4160382] [PubMed: 25014540]
Höckel M, Dornhöfer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol. 2006 Oct;7(10):837-47. [PubMed: 17012046]
Magrina JF, Stanhope CR, Weaver AL. Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol. 1997 Jan;64(1):130-5. [PubMed: 8995561]
Bourke J, Wong K, Srinivasjois R, Pereira G, Shepherd CCJ, White SW, Stanley F, Leonard H. Predicting Long-Term Survival Without Major Disability for Infants Born Preterm. J Pediatr. 2019 Dec;215:90-97.e1. [PubMed: 31493909]
Zanotti-Fregonara P, Laforest R, Wallis JW. Fetal Radiation Dose from 18F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR. J Nucl Med. 2015 Aug;56(8):1218-22. [PubMed: 26089550]
Alouini S, Rida K, Mathevet P. Cervical cancer complicating pregnancy: implications of laparoscopic lymphadenectomy. Gynecol Oncol. 2008 Mar;108(3):472-7. [PubMed: 18201752]
Bernardini F, Ferrandina G, Ricci C, fa*gotti A, Fanfani F, Cavaliere AF, Gui B, Scambia G, De Vincenzo R. Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study. Curr Oncol. 2022 Aug 14;29(8):5702-5714. [PMC free article: PMC9406620] [PubMed: 36005188]
Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R, Fumagalli M, Halaska MJ, Hasenburg A, Johansson ALV, Lambertini M, Lok CAR, Maggen C, Morice P, Peccatori F, Poortmans P, Van Calsteren K, Vandenbroucke T, van Gerwen M, van den Heuvel-Eibrink M, Zagouri F, Zapardiel I. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol. 2019 Oct 01;30(10):1601-1612. [PubMed: 31435648]
Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L, Mangioni C. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997 Aug 23;350(9077):535-40. [PubMed: 9284774]
Landoni F, Colombo A, Milani R, Placa F, Zanagnolo V, Mangioni C. Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update. J Gynecol Oncol. 2017 May;28(3):e34. [PMC free article: PMC5391393] [PubMed: 28382797]
van Kol K, Ebisch R, Piek J, Beugeling M, Vergeldt T, Bekkers R. Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate. Cancers (Basel). 2021 Dec 08;13(24) [PMC free article: PMC8699574] [PubMed: 34944810]
Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999 Apr 15;340(15):1137-43. [PubMed: 10202164]
Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol. 1999 May;73(2):177-83. [PubMed: 10329031]
Levinson K, Beavis AL, Purdy C, Rositch AF, Viswanathan A, Wolfson AH, Kelly MG, Tewari KS, McNally L, Guntupalli SR, Ragab O, Lee YC, Miller DS, Huh WK, Wilkinson KJ, Spirtos NM, Van Le L, Casablanca Y, Holman LL, Waggoner SE, Fader AN. Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis. Gynecol Oncol. 2021 Sep;162(3):532-538. [PMC free article: PMC8405564] [PubMed: 34217544]
Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W, Alberts DS. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000 Apr;18(8):1606-13. [PubMed: 10764420]
Huang H, Feng YL, Wan T, Zhang YN, Cao XP, Huang YW, Xiong Y, Huang X, Zheng M, Li YF, Li JD, Chen GD, Li H, Chen YL, Ma LG, Yang HY, Li L, Yao SZ, Ye WJ, Tu H, Huang QD, Liang LZ, Liu FY, Liu Q, Liu JH. Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer: The STARS Phase 3 Randomized Clinical Trial. JAMA Oncol. 2021 Mar 01;7(3):361-369. [PMC free article: PMC7809615] [PubMed: 33443541]
Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, Michalski J, Bosch W, Straube W, Schwarz J, Lowenstein J, Jiang SB, Saenz CC, Plaxe S, Einck J, Khorprasert C, Koonings P, Harrison T, Shi M, Mundt AJ., INTERTECC Study Group. Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2). Int J Radiat Oncol Biol Phys. 2017 Mar 01;97(3):536-545. [PubMed: 28126303]
Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Bruner DW, Kachnic LA. Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study. J Clin Oncol. 2020 May 20;38(15):1685-1692. [PMC free article: PMC7238486] [PubMed: 32073955]
Gonzalez VJ, Hullett CR, Burt L, Rassiah-Szegedi P, Sarkar V, Tward JD, Hazard LJ, Huang YJ, Salter BJ, Gaffney DK. Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy. Adv Radiat Oncol. 2017 Apr-Jun;2(2):235-243. [PMC free article: PMC5514253] [PubMed: 28740937]
Small W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008 Jun 01;71(2):428-34. [PMC free article: PMC2752724] [PubMed: 18037584]
Ríos I, Vásquez I, Cuervo E, Garzón Ó, Burbano J. Problems and solutions in IGRT for cervical cancer. Rep Pract Oncol Radiother. 2018 Nov-Dec;23(6):517-527. [PMC free article: PMC6277271] [PubMed: 30534015]
Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, Miften M. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010 Mar 01;76(3 Suppl):S101-7. [PubMed: 20171503]
Viswanathan AN, Thomadsen B., American Brachytherapy Society Cervical Cancer Recommendations Committee. American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy. 2012 Jan-Feb;11(1):33-46. [PubMed: 22265436]
Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B., American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012 Jan-Feb;11(1):47-52. [PMC free article: PMC3489267] [PubMed: 22265437]
Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, Castelain B, Thomas L, Peiffert D. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol. 2012 Jun;103(3):305-13. [PubMed: 22633469]
Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C, Lindegaard JC., EMBRACE Collaborative Group. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021 Apr;22(4):538-547. [PubMed: 33794207]
Dimopoulos JC, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, Pedersen EM, van Limbergen E, Haie-Meder C, Pötter R. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012 Apr;103(1):113-22. [PMC free article: PMC3336085] [PubMed: 22296748]
Banerjee R, Kamrava M. Brachytherapy in the treatment of cervical cancer: a review. Int J Womens Health. 2014;6:555-64. [PMC free article: PMC4045176] [PubMed: 24920937]
Liu R, Wang X, Tian JH, Yang K, Wang J, Jiang L, Hao XY. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst Rev. 2014 Oct 09;2014(10):CD007563. [PMC free article: PMC8734152] [PubMed: 25300170]
Report 89. J ICRU. 2013 Apr;13(1-2):NP. [PubMed: 27335498]
Mazeron R, Fokdal LU, Kirchheiner K, Georg P, Jastaniyah N, Šegedin B, Mahantshetty U, Hoskin P, Jürgenliemk-Schulz I, Kirisits C, Lindegaard JC, Dörr W, Haie-Meder C, Tanderup K, Pötter R., EMBRACE collaborative group. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study. Radiother Oncol. 2016 Sep;120(3):412-419. [PubMed: 27396811]
Lucidarme D, Marteau P, Foucault M, Vautrin B, Filoche B. Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis. Aliment Pharmacol Ther. 1997 Apr;11(2):335-40. [PubMed: 9146772]
Rigaud J, Hetet JF, Bouchot O. [Management of radiation cystitis]. Prog Urol. 2004 Sep;14(4):568-72. [PubMed: 15776916]
Pereira D, Ferreira C, Catarino R, Correia T, Cardoso A, Reis F, Cerqueira M, Prisco R, Camacho O. Hyperbaric oxygen for radiation-induced cystitis: A long-term follow-up. Actas Urol Esp (Engl Ed). 2020 Oct;44(8):561-567. [PubMed: 32736899]
Boice JD, Day NE, Andersen A, Brinton LA, Brown R, Choi NW, Clarke EA, Coleman MP, Curtis RE, Flannery JT. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst. 1985 May;74(5):955-75. [PubMed: 3858584]
Wright JD, St Clair CM, Deutsch I, Burke WM, Gorrochurn P, Sun X, Herzog TJ. Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma. Cancer. 2010 May 15;116(10):2486-92. [PubMed: 20209618]
Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005 Jul 01;62(3):738-44. [PubMed: 15936554]
Small W, Kim YS, Joyce C, Surucu M, Leshyk M, Harkenrider MM, Potkul RK, Liotta M, Winder A, Altoos B. Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management. Brachytherapy. 2021 May-Jun;20(3):557-564. [PubMed: 33741275]
van Dyk S, Schneider M, Kondalsamy-Chennakesavan S, Bernshaw D, Narayan K. Ultrasound use in gynecologic brachytherapy: Time to focus the beam. Brachytherapy. 2015 May-Jun;14(3):390-400. [PubMed: 25620161]
Rowlands S, Oloto E, Horwell DH. Intrauterine devices and risk of uterine perforation: current perspectives. Open Access J Contracept. 2016;7:19-32. [PMC free article: PMC5683155] [PubMed: 29386934]
Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999 Apr 15;340(15):1144-53. [PubMed: 10202165]
Dueñas-González A, Zarbá JJ, Patel F, Alcedo JC, Beslija S, Casanova L, Pattaranutap*rn P, Hameed S, Blair JM, Barraclough H, Orlando M. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011 May 01;29(13):1678-85. [PubMed: 21444871]
Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, Miller DS, Olt G, King S, Boggess JF, Rocereto TF. Phase III study of cisplatin with or without pacl*taxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol. 2004 Aug 01;22(15):3113-9. [PubMed: 15284262]
Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, Benda J, Cella D. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2009 Oct 01;27(28):4649-55. [PMC free article: PMC2754911] [PubMed: 19720909]
Tewari KS, Sill MW, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, DiSaia PJ, Copeland LJ, Creasman WT, Stehman FB, Brady MF, Burger RA, Thigpen JT, Birrer MJ, Waggoner SE, Moore DH, Look KY, Koh WJ, Monk BJ. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017 Oct 07;390(10103):1654-1663. [PMC free article: PMC5714293] [PubMed: 28756902]
Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord JP, Geva R, Gottfried M, Penel N, Hansen AR, Piha-Paul SA, Doi T, Gao B, Chung HC, Lopez-Martin J, Bang YJ, Frommer RS, Shah M, Ghori R, Joe AK, Pruitt SK, Diaz LA. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. J Clin Oncol. 2020 Jan 01;38(1):1-10. [PMC free article: PMC8184060] [PubMed: 31682550]
Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, Tewari KS, Salman P, Hoyos Usta E, Yañez E, Gümüş M, Olivera Hurtado de Mendoza M, Samouëlian V, Castonguay V, Arkhipov A, Toker S, Li K, Keefe SM, Monk BJ., KEYNOTE-826 Investigators. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer. N Engl J Med. 2021 Nov 11;385(20):1856-1867. [PubMed: 34534429]
Nishio S, Yonemori K, Usami T, Minobe S, Yunokawa M, Iwata T, Okamoto A, Aoki Y, Itamochi H, Takekuma M, Harano K, Yamamoto K, Maruko T, Ugai H, Tekin C, Colombo N, Fujiwara K, Hasegawa K, Ushijima K. Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826. Cancer Sci. 2022 Nov;113(11):3877-3887. [PMC free article: PMC9633308] [PubMed: 35792064]
Kitagawa R, Katsumata N, Shibata T, Kamura T, Kasamatsu T, Nakanishi T, Nishimura S, Ushijima K, Takano M, Satoh T, Yoshikawa H. Pacl*taxel Plus Carboplatin Versus Pacl*taxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505. J Clin Oncol. 2015 Jul 01;33(19):2129-35. [PubMed: 25732161]
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. [PMC free article: PMC9298213] [PubMed: 34669203]
Saleh M, Virarkar M, Javadi S, Elsherif SB, de Castro Faria S, Bhosale P. Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging. AJR Am J Roentgenol. 2020 May;214(5):1182-1195. [PubMed: 32182097]
Salib MY, Russell JHB, Stewart VR, Sudderuddin SA, Barwick TD, Rockall AG, Bharwani N. 2018 FIGO Staging Classification for Cervical Cancer: Added Benefits of Imaging. Radiographics. 2020 Oct;40(6):1807-1822. [PubMed: 32946322]
Castellano T, Ding K, Moore KN, Landrum LM. Simple Hysterectomy for Cervical Cancer: Risk Factors for Failed Screening and Deviation From Screening Guidelines. J Low Genit Tract Dis. 2019 Apr;23(2):124-128. [PubMed: 30817687]
Chen HH, Meng WY, Li RZ, Wang QY, Wang YW, Pan HD, Yan PY, Wu QB, Liu L, Yao XJ, Kang M, Leung EL. Potential prognostic factors in progression-free survival for patients with cervical cancer. BMC Cancer. 2021 May 10;21(1):531. [PMC free article: PMC8112015] [PubMed: 33971846]
Rauh-Hain JA, Clemmer JT, Bradford LS, Clark RM, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Racial disparities in cervical cancer survival over time. Cancer. 2013 Oct 15;119(20):3644-52. [PubMed: 23913530]
Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy. 2019 Jan-Feb;18(1):29-37. [PMC free article: PMC6338515] [PubMed: 30361045]
Pergialiotis V, Bellos I, Thomakos N, Haidopoulos D, Perrea DN, Kontzoglou K, Daskalakis G, Rodolakis A. Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: A systematic review of the literature. Oncol Rev. 2019 Jan 14;13(1):387. [PMC free article: PMC6340308] [PubMed: 30746036]
Mendu S, Boukhechba M, Gordon JR, Datta D, Molina E, Arroyo G, Proctor SK, Wells KJ, Barnes LE. Design of a Culturally-Informed Virtual Human for Educating Hispanic Women about Cervical Cancer. Int Conf Pervasive Comput Technol Healthc. 2018 May;2018:360-366. [PMC free article: PMC6292436] [PubMed: 30555731]
Nasser S, Berek J, Ullrich A, Giordano L, Sehouli J. A report on the Marrakech International Women's Cancer Days: dialogs and implications. Int J Gynecol Cancer. 2019 Feb;29(2):417-421. [PubMed: 30718317]
Cunningham-Erves J, Forbes L, Ivankova N, Mayo-Gamble T, Kelly-Taylor K, Deakings J. Black mother's intention to vaccinate daughters against HPV: A mixed methods approach to identify opportunities for targeted communication. Gynecol Oncol. 2018 Jun;149(3):506-512. [PMC free article: PMC7319039] [PubMed: 29588103]
Mabelele MM, Materu J, Ng'ida FD, Mahande MJ. Knowledge towards cervical cancer prevention and screening practices among women who attended reproductive and child health clinic at Magu district hospital, Lake Zone Tanzania: a cross-sectional study. BMC Cancer. 2018 May 16;18(1):565. [PMC free article: PMC5956852] [PubMed: 29769124]
Lai D, Bodson J, Davis FA, Lee D, Tavake-Pasi F, Napia E, Villalta J, Mukundente V, Mooney R, Coulter H, Stark LA, Sanchez-Birkhead AC, Kepka D. Diverse Families' Experiences with HPV Vaccine Information Sources: A Community-Based Participatory Approach. J Community Health. 2017 Apr;42(2):400-412. [PMC free article: PMC5337438] [PubMed: 27734247]
Spinner C, Ding L, Bernstein DI, Brown DR, Franco EL, Covert C, Kahn JA. Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women. Pediatrics. 2019 Feb;143(2) [PMC free article: PMC6361347] [PubMed: 30670582]
Bayu H, Berhe Y, Mulat A, Alemu A. Cervical Cancer Screening Service Uptake and Associated Factors among Age Eligible Women in Mekelle Zone, Northern Ethiopia, 2015: A Community Based Study Using Health Belief Model. PLoS One. 2016;11(3):e0149908. [PMC free article: PMC4786115] [PubMed: 26963098]
Kung TH, Gordon JR, Abdullahi A, Barve A, Chaudhari V, Kosambiya JK, Kumar A, Gamit S, Wells KJ. "My husband says this: If you are alive, you can be someone…": Facilitators and barriers to cervical cancer screening among women living with HIV in India. Cancer Causes Control. 2019 Apr;30(4):365-374. [PMC free article: PMC6461359] [PubMed: 30809741]
McPherson GS, Fairbairn-Dunlop P, Payne D. Overcoming Barriers to Cervical Screening Among Pacific Women: A Narrative Review. Health Equity. 2019;3(1):22-29. [PMC free article: PMC6379043] [PubMed: 30783634]
